US Broker Ratings

Liquidia Corporation (LQDA) Stock Analysis: Exploring the 4,158% Revenue Growth and Its Impact on Future Prospects

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical leader in developing treatments for rare cardiopulmonary diseases, has recently caught the attention of investors with its impressive financial metrics..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Capitalizing on a 40% Upside Potential

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a prominent player in the healthcare sector, specializes in the development and manufacturing of branded and generic pharmaceutical products. With a..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: High ROE and Revenue Growth Signal Promising Prospects

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is carving out a notable presence in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Atlanta,..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a Potential 132% Upside in Biotech

Vera Therapeutics, Inc. (NASDAQ: VERA) presents an intriguing opportunity for investors with a keen interest in the biotechnology sector. This clinical-stage company, headquartered in Brisbane, California,..

LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator with Compelling Revenue Growth and Analyst Confidence

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, specifically within the medical devices industry, is gaining attention for its noteworthy performance metrics and..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Navigating Challenges with a $6.27 Billion Market Cap

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a biotechnology company focused on orexin-based neuroscience therapeutics, presents a fascinating case for investors intrigued by the potential of emerging healthcare..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with Virtual Healthcare Potential

Teladoc Health, Inc. (NYSE: TDOC), a pioneer in the virtual healthcare landscape, finds itself at a critical juncture. With a market capitalization of $1.61 billion, this..

Kiniksa Pharmaceuticals Interna (KNSA) Investor Outlook: Analyzing a 10% Upside Potential in the Biopharma Sector

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) stands out as a compelling player within the healthcare sector, specifically in the drug manufacturing domain. With a robust market..

Enovis Corporation (ENOV) Stock Analysis: A 44% Potential Upside in the Healthcare Sector

Enovis Corporation (NYSE: ENOV), a prominent player in the medical devices industry, presents an intriguing opportunity for investors looking to capitalize on its potential growth in..

Bausch Health Companies Inc. (BHC) Stock Analysis: Potential 62.95% Upside Amidst Mixed Signals

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector, has caught the eye of investors with its potential upside of nearly 63%...

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: A Healthcare Innovator with Explosive Revenue Growth

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is making waves in the biotechnology sector with its focus on developing innovative treatments for rare endocrine diseases and endocrine-related tumors...

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 58% Potential Upside in the Biotech Sector

Biohaven Ltd. (NASDAQ: BHVN), a dynamic player in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to the healthcare industry. With a market..

Kestra Medical Technologies (KMTS) Stock Analysis: A 31.46% Potential Upside Beckons Investors

Investors looking for opportunities in the healthcare sector may want to turn their attention to Kestra Medical Technologies, Lt (KMTS), a promising player in the medical..

UFP Technologies, Inc. (UFPT) Stock Analysis: Unveiling a 30.52% Upside Potential

UFP Technologies, Inc. (NASDAQ: UFPT) presents a compelling investment opportunity within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $1.92..

PROCEPT BioRobotics Corporation (PRCT) Investor Outlook: Exploring a 65% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a leader in the medical devices sector, has been making waves with its innovative approach to urological surgery. As a surgical..

CONMED Corporation (CNMD)

⚠️ No article content returned.

..

Recursion Pharmaceuticals (RXRX): Investor Outlook Highlights 140% Upside Potential Amid Innovative Drug Discovery

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is capturing investor attention with its ambitious approach to drug discovery and a potential upside of 140.86% as suggested by its..

Indivior Pharmaceuticals, Inc. (INDV) Stock Analysis: A Compelling 26.99% Upside in the Healthcare Sector

Indivior Pharmaceuticals, Inc. (NASDAQ: INDV) is generating significant interest among investors, not least due to its strong potential upside of nearly 27%. This Virginia-based company specializes..

Astrana Health Inc. (ASTH) Stock Analysis: Revenue Growth Shines with 29% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH), a key player in the healthcare sector, is garnering significant attention from investors due to its robust revenue growth and potential..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Investor Outlook with a 5.30% Upside Potential

In the dynamic landscape of health information services, GoodRx Holdings, Inc. (NASDAQ: GDRX) presents an intriguing investment opportunity. As a leader in the sector, GoodRx provides..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds